Company Nexstim Oyj Nasdaq Helsinki
Equities
NXTMH
FI4000102678
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Navigated Brain Stimulation Systems
42.9
%
| 2 | 23.6 % | 3 | 42.9 % | +38.51% |
Navigated Brain Therapy Systems Continuous
27.4
%
| 2 | 18.3 % | 2 | 27.4 % | +13.58% |
Navigated Brain Stimulation Systems Continuous
16.3
%
| 1 | 12.3 % | 1 | 16.3 % | +0.52% |
Navigated Brain Therapy Systems
13.4
%
| 1 | 8.7 % | 1 | 13.4 % | +17.69% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
44.8
%
| 6 | 64.2 % | 3 | 44.8 % | -46.88% |
Rest of Europe
30.9
%
| 1 | 14.4 % | 2 | 30.9 % | +63.57% |
Finland
20.6
%
| 2 | 18.9 % | 1 | 20.6 % | -17.07% |
Other
3.6
%
| 0 | 2.5 % | 0 | 3.6 % | +8.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | 18/14/18 | |
Director of Finance/CFO | 38 | 01/14/01 | |
Gustaf Järnefelt
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/08/01 |
Jarmo Laine
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/08/01 |
Hanna Kotola
LAW | General Counsel | - | 01/17/01 |
Henri Hannula
SAM | Sales & Marketing | 50 | 01/01/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 11/19/11 | |
Director/Board Member | 53 | 01/21/01 | |
Director/Board Member | 65 | 01/21/01 | |
Chairman | 61 | 11/19/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,765,562 | 3,462,766 ( 51.18 %) | 0 | 51.18 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |